Sun Pharma, Lupin recall drugs in US market: USFDA

LIC reduces stake in Sun Pharma, sells shares worth Rs 3,882 crore in a little over one year

Sun Pharma to acquire 11.28 pc stake in Zenotech from Daiichi Sankyo

Sun Pharma, Lupin recall products in US market

Sun Pharma recalls over 1.10 lakh bottles of generic drug in US market

Sun Pharma settles patent litigation with Celgene Corporation for cancer drug Revlimid

No plans to get into vaccine production as it requires separate manufacturing infra: Sun Pharma

Sun Pharma to launch complete range of generic anti-epilepsy drug

Sensex rises over 250 points to record peak in early trade; Nifty above 13,550

Sun Pharma starts testing plant-based drug as potential treatment for Covid-19

Covid-19 treatment: Sun Pharma gets DCGI approval for Nafamostat clinical trial in patients

Latest Additions

Injuries don’t define you: Mohammed Shami shares rehab update

Shivakumar desperately wants to become CM, says K’taka BJP chief Vijayendra

Scribe throws lapel microphone towards Sharad Pawar in Baramati; cops give clean chit

India delivers first batch of BrahMos missiles to Philippines

Air India cancels Dubai flights due to operational disruptions

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.